Hipgnosis expands portfolio with acquisition of Lindsey Buckingham and Jimmy Iovine catalogues

Music fund goes its own way with big-name deals

Lindsey Buckingham. Photo: Raph_PH/Flickr CC BY 2.0

Lindsey Buckingham. Photo: Raph_PH/Flickr CC BY 2.0

Hipgnosis Songs Fund has added the music catalogue of Lindsey Buckingham, former lead vocalist and guitarist in Fleetwood Mac, to its portfolio, having announced the acquisition of record executive Jimmy Iovine's music catalogue yesterday (4 January).

The fund announced it has now, together with a 25% share snapped up on 30 September 2020, acquired 100% of Buckingham's music publishing rights, including his publishing and writer's share, of his entire catalogue comprising 161 songs, as well as a 50% share of any unreleased compositions. Hipgnosis has also purchased 100% of Iovine's catalogue of worldwide producer royalties, comprising 259 songs and his film production royalties for 8 Mile and Get Rich or Die Tryin'. Buckingham's music career took off in the 1970s when he and his then partner - and current Fleetwood Mac vocalist - S...

To continue reading this article...

Join Investment Week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on Investment Trusts

abrdn's Bruce Stout said the most "corrosive" of all factors was the "tangible change in sentiment"

Discount narrows on Murray International as it delivers positive returns

9.5% share price total return

Kathleen Gallagher
clock 12 August 2022 • 2 min read
Rob Murphy, managing director of financials at Edison Group

Investment companies can provide returns despite market uncertainty

Increase exposure to ESG

Rob Murphy
clock 11 August 2022 • 4 min read
Ali H. Munawar, CEO of Pledge Therapeutics

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read